Halper Sadeh Investigates Penumbra and Others for Potential Violations
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 21 2026
0mins
Should l Buy FONR?
Source: PRnewswire
- Penumbra Acquisition Investigation: Halper Sadeh LLC is investigating Penumbra, Inc. (NYSE:PEN) regarding its sale to Boston Scientific Corporation for $374 million in cash or 3.8721 shares, potentially violating fiduciary duties to shareholders and impacting their rights.
- FONAR Shareholder Rights Issues: The sale of FONAR Corporation (NASDAQ:FONR) to its CEO and certain executives for $19.00 per share for Class B and $6.34 for Class C stock has raised concerns from Halper Sadeh, potentially affecting shareholder rights.
- Green Dot Transaction Investigation: Halper Sadeh is assessing Green Dot Corporation's (NYSE:GDOT) sale for $8.11 in cash and 0.2215 shares of a new publicly traded bank holding company, potentially seeking increased compensation for shareholders.
- Legal Consultation Services: Halper Sadeh LLC offers free legal consultations, encouraging shareholders to discuss their rights, demonstrating the firm's commitment to protecting investor interests and potentially securing additional benefits for shareholders.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy FONR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on FONR
About FONR
FONAR Corporation is engaged in the research, development, production and marketing of medical scanning equipment, which uses principles of Magnetic Resonance Imaging (MRI) for the detection and diagnosis of human diseases. The Company conducts its business in two segments: medical equipment and physician management and diagnostic services. Its medical equipment segment is conducted directly through the Company. Its physician management and diagnostic services segment is conducted through its subsidiary, Health Management Corporation of America (HMCA). Its signature product is the FONAR UPRIGHT Multi-Position MRI (STAND-UP MRI). HMCA provides management services, administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, hiring, maintenance service, and clerical and other non-medical personnel to medical providers engaged in diagnostic imaging. HMCA owns and operates six diagnostic imaging facilities in Florida.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investigation Launched into FONAR's Transaction Dealings
- Shareholder Rights Investigation: Ademi LLP is investigating FONAR (NASDAQ:FONR) for potential breaches of fiduciary duty and legal violations related to its transaction with Timothy Damadian and the management team, raising concerns about shareholder rights.
- Transaction Details Revealed: In this deal, FONAR shareholders are set to receive $19.00 per share for common stock, $6.34 for Class C common stock, and $10.50 for Class A non-voting preferred stock, indicating a substantial return on investment.
- Insider Benefit Concerns: FONAR insiders are expected to receive significant benefits as part of the change of control arrangements, prompting questions about whether the board is fulfilling its fiduciary duties to all shareholders, which could impact corporate governance.
- Competing Transaction Restrictions: The transaction agreement imposes significant penalties on FONAR for accepting competing bids, potentially limiting future acquisition opportunities and negatively affecting the company's competitive position in the market.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigations: Halper Sadeh LLC is investigating VerifyMe, Inc. (NASDAQ:VRME) for potential fiduciary duty breaches related to its merger with Open World Ltd., which may impact shareholder rights.
- Shareholder Rights Protection: Allegiant Travel Company (NASDAQ:ALGT) shareholders will own approximately 67% of the combined entity post-merger with Sun Country Airlines, prompting Halper Sadeh LLC to encourage shareholders to understand their legal rights.
- Cash Acquisition Deal: European Wax Center, Inc. (NASDAQ:EWCZ) is being sold to General Atlantic for $5.80 per share in cash, with Halper Sadeh LLC advising shareholders to be aware of their legal rights and options.
- Management Buyout: FONAR Corporation (NASDAQ:FONR) is being sold to CEO Timothy Damadian and certain executives for $19.00 per share for Class B stock and $6.34 for Class C stock, with Halper Sadeh LLC potentially seeking increased compensation and disclosures for shareholders.
See More
Monteverde Law Firm Investigates Multiple Mergers
- Merger Investigation: Monteverde & Associates is investigating the merger between Roman DBDR Acquisition Corp. II and Thomas Lloyd Climate Solutions B.V., aiming to recover losses for shareholders and showcasing its expertise in securities class actions.
- AES Transaction: The AES Corporation is set to be sold to Horizon Parent, L.P. for $15.00 per share in cash, providing shareholders with direct cash returns and reflecting the company's market valuation.
- FONAR Shareholder Returns: FONAR Corporation's Class B common stockholders will receive $19.00 per share, while Class C stockholders will get $6.34 per share, indicating substantial returns for shareholders and transparency in corporate governance.
- Devon Energy Merger: The merger with Coterra Energy, Inc. will allow Devon shareholders to own approximately 54% of the combined entity, highlighting the company's strategic position in industry consolidation and future growth potential.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Merger Investigation: Halper Sadeh LLC is investigating the merger between Contango ORE, Inc. and Dolly Varden Silver Corporation, where Contango shareholders are expected to own approximately 50% of the combined entity, potentially impacting shareholder rights and future returns.
- FONAR Shareholder Rights: FONAR Corporation is being sold to its CEO and certain executives at $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, raising concerns about potential conflicts of interest among management.
- Clearwater Acquisition Details: Clearwater Analytics Holdings, Inc. is being sold to Permira and Warburg Pincus for $24.55 per share in cash, with terms that may affect shareholder rights, prompting Halper Sadeh LLC to seek increased consideration.
- Legal Rights Consultation: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options at no cost, indicating the firm's commitment to protecting investor interests and potentially advocating for higher transaction compensation.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Legal Investigation Initiated: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc. (NASDAQ: RAPT) regarding its sale to GSK plc for $58.00 per share, potentially violating fiduciary duties to shareholders and impacting shareholder rights.
- Shareholder Rights Protection: The transaction between Penumbra, Inc. (NYSE: PEN) and Boston Scientific Corporation involves $374.00 in cash or 3.8721 shares of Boston Scientific common stock per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
- Cash and Stock Transaction: Calavo Growers, Inc. (NASDAQ: CVGW) is selling to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock per share, prompting Halper Sadeh LLC to assess the potential impact of this transaction on shareholders.
- Management Transaction Review: FONAR Corporation (NASDAQ: FONR) is involved in a transaction with its CEO and certain executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC possibly advocating for enhanced shareholder rights.
See More
Investigation Alerts for Multiple Company Mergers
- RAPT Acquisition Investigation: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, totaling an estimated equity value of $2.2 billion, with investigations focusing on whether the board failed to conduct a fair process, potentially impacting shareholder rights.
- Calavo Merger Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the transaction at approximately $430 million, while investigations examine if the board breached fiduciary duties to shareholders.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valuing the company at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations looking into whether the board ensured a fair process, potentially affecting shareholder interests.
- FONAR Merger Investigation: FONAR Corporation is to be acquired by FONAR, LLC for $19 per share in an all-cash transaction, with investigations questioning whether the board failed to conduct a fair process, which could impact shareholder rights.
See More
Investigation Launched into FONAR's Transaction Dealings
- Shareholder Rights Investigation: Ademi LLP is investigating FONAR (NASDAQ:FONR) for potential breaches of fiduciary duty and legal violations related to its transaction with Timothy Damadian and the management team, raising concerns about shareholder rights.
- Transaction Details Revealed: In this deal, FONAR shareholders are set to receive $19.00 per share for common stock, $6.34 for Class C common stock, and $10.50 for Class A non-voting preferred stock, indicating a substantial return on investment.
- Insider Benefit Concerns: FONAR insiders are expected to receive significant benefits as part of the change of control arrangements, prompting questions about whether the board is fulfilling its fiduciary duties to all shareholders, which could impact corporate governance.
- Competing Transaction Restrictions: The transaction agreement imposes significant penalties on FONAR for accepting competing bids, potentially limiting future acquisition opportunities and negatively affecting the company's competitive position in the market.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Merger Investigations: Halper Sadeh LLC is investigating VerifyMe, Inc. (NASDAQ:VRME) for potential fiduciary duty breaches related to its merger with Open World Ltd., which may impact shareholder rights.
- Shareholder Rights Protection: Allegiant Travel Company (NASDAQ:ALGT) shareholders will own approximately 67% of the combined entity post-merger with Sun Country Airlines, prompting Halper Sadeh LLC to encourage shareholders to understand their legal rights.
- Cash Acquisition Deal: European Wax Center, Inc. (NASDAQ:EWCZ) is being sold to General Atlantic for $5.80 per share in cash, with Halper Sadeh LLC advising shareholders to be aware of their legal rights and options.
- Management Buyout: FONAR Corporation (NASDAQ:FONR) is being sold to CEO Timothy Damadian and certain executives for $19.00 per share for Class B stock and $6.34 for Class C stock, with Halper Sadeh LLC potentially seeking increased compensation and disclosures for shareholders.
See More
Monteverde Law Firm Investigates Multiple Mergers
- Merger Investigation: Monteverde & Associates is investigating the merger between Roman DBDR Acquisition Corp. II and Thomas Lloyd Climate Solutions B.V., aiming to recover losses for shareholders and showcasing its expertise in securities class actions.
- AES Transaction: The AES Corporation is set to be sold to Horizon Parent, L.P. for $15.00 per share in cash, providing shareholders with direct cash returns and reflecting the company's market valuation.
- FONAR Shareholder Returns: FONAR Corporation's Class B common stockholders will receive $19.00 per share, while Class C stockholders will get $6.34 per share, indicating substantial returns for shareholders and transparency in corporate governance.
- Devon Energy Merger: The merger with Coterra Energy, Inc. will allow Devon shareholders to own approximately 54% of the combined entity, highlighting the company's strategic position in industry consolidation and future growth potential.
See More
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
- Merger Investigation: Halper Sadeh LLC is investigating the merger between Contango ORE, Inc. and Dolly Varden Silver Corporation, where Contango shareholders are expected to own approximately 50% of the combined entity, potentially impacting shareholder rights and future returns.
- FONAR Shareholder Rights: FONAR Corporation is being sold to its CEO and certain executives at $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, raising concerns about potential conflicts of interest among management.
- Clearwater Acquisition Details: Clearwater Analytics Holdings, Inc. is being sold to Permira and Warburg Pincus for $24.55 per share in cash, with terms that may affect shareholder rights, prompting Halper Sadeh LLC to seek increased consideration.
- Legal Rights Consultation: Halper Sadeh LLC encourages shareholders to contact them to discuss their rights and options at no cost, indicating the firm's commitment to protecting investor interests and potentially advocating for higher transaction compensation.
See More
Investor Rights Law Firm Investigates Multiple Companies
- Legal Investigation Initiated: Halper Sadeh LLC is investigating RAPT Therapeutics, Inc. (NASDAQ: RAPT) regarding its sale to GSK plc for $58.00 per share, potentially violating fiduciary duties to shareholders and impacting shareholder rights.
- Shareholder Rights Protection: The transaction between Penumbra, Inc. (NYSE: PEN) and Boston Scientific Corporation involves $374.00 in cash or 3.8721 shares of Boston Scientific common stock per share, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures for shareholders.
- Cash and Stock Transaction: Calavo Growers, Inc. (NASDAQ: CVGW) is selling to Mission Produce, Inc. for $14.85 in cash and 0.9790 shares of Mission stock per share, prompting Halper Sadeh LLC to assess the potential impact of this transaction on shareholders.
- Management Transaction Review: FONAR Corporation (NASDAQ: FONR) is involved in a transaction with its CEO and certain executives for $19.00 per share for Class B common stock and $6.34 per share for Class C common stock, with Halper Sadeh LLC possibly advocating for enhanced shareholder rights.
See More
Investigation Alerts for Multiple Company Mergers
- RAPT Acquisition Investigation: RAPT Therapeutics is set to be acquired by GlaxoSmithKline for $58 per share, totaling an estimated equity value of $2.2 billion, with investigations focusing on whether the board failed to conduct a fair process, potentially impacting shareholder rights.
- Calavo Merger Details: Calavo Growers will be acquired by Mission Produce, with shareholders receiving $27 per share, including $14.85 in cash and 0.9790 shares of Mission, valuing the transaction at approximately $430 million, while investigations examine if the board breached fiduciary duties to shareholders.
- Penumbra Acquisition Status: Penumbra will be acquired by Boston Scientific in a deal valuing the company at $374 per share, reflecting an enterprise value of about $14.5 billion, with investigations looking into whether the board ensured a fair process, potentially affecting shareholder interests.
- FONAR Merger Investigation: FONAR Corporation is to be acquired by FONAR, LLC for $19 per share in an all-cash transaction, with investigations questioning whether the board failed to conduct a fair process, which could impact shareholder rights.
See More
